or Try an Advanced Search...

    Technical Analysis for BFRI - Biofrontera Inc.

    Grade Last Price % Change Price Change
    D 1.05 -0.94% -0.01
    BFRI closed down 0.94 percent on Friday, May 24, 2024, on 25 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical BFRI trend table...
    Date Alert Name Type % Chg
    Hammer Candlestick Bullish 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion -0.94%
    Oversold Stochastic Weakness -0.94%
    Narrow Range Bar Range Contraction -7.89%
    Wide Bands Range Expansion -7.89%
    Up 3 Days in a Row Strength -7.89%
    Older End-of-Day Signals for BFRI ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 4 days ago
    60 Minute Opening Range Breakdown 4 days ago
    Down 5% 4 days ago
    Down 3% 4 days ago
    Fell Below Previous Day's Low 4 days ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    BFRI Chart by TradingView
    Basic chart:

    Profile

    Biofrontera Inc., a biopharmaceutical company, develops and provides dermatological products for the treatment of skin diseases in the United States. It primarily develops therapies for non-melanoma skin cancer. It offers Ameluz, an aminolevulinic acid hydrochloride gel for the photodynamic therapy of actinic keratoses; and BF-RhodoLED, an LED lamp emitting red light for use in photodynamic therapy. The company was founded in 1997 and is based in Woburn, Massachusetts.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Biopharmaceutical Clinical Medicine Health Sciences Melanoma Antineoplastic Drugs Dermatology Medical Physics Laser Medicine Skin Diseases Light Therapy Treatment Of Skin Diseases Actinic Keratosis Non Melanoma Skin Cancer

    Is BFRI a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 16 Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript
    May 15 Biofrontera GAAP EPS of -$2.88, revenue of $7.9M
    May 15 Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update
    May 6 Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024
    May 3 Biofrontera files to sell 11.31M shares for holders
    May 3 Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants
    Mar 26 Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
    Mar 19 Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript
    Mar 19 Q4 2023 Biofrontera Inc Earnings Call
    Mar 18 Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript
    See more BFRI news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.42
    52 Week Low 0.61
    Average Volume 106,715
    200-Day Moving Average 3.71
    50-Day Moving Average 1.54
    20-Day Moving Average 1.40
    10-Day Moving Average 1.13
    Average True Range 0.19
    RSI (14) 36.31
    ADX 18.18
    +DI 16.86
    -DI 26.80
    Chandelier Exit (Long, 3 ATRs) 1.57
    Chandelier Exit (Short, 3 ATRs) 1.56
    Upper Bollinger Bands 2.01
    Lower Bollinger Band 0.79
    Percent B (%b) 0.21
    BandWidth 87.20
    MACD Line -0.16
    MACD Signal Line -0.12
    MACD Histogram -0.0348
    Fundamentals Value
    Market Cap 1.77 Million
    Num Shares 1.68 Million
    EPS -20.36
    Price-to-Earnings (P/E) Ratio -0.05
    Price-to-Sales 0.04
    Price-to-Book 1.18
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.15
    Resistance 3 (R3) 1.15 1.11 1.14
    Resistance 2 (R2) 1.11 1.08 1.11 1.13
    Resistance 1 (R1) 1.08 1.07 1.06 1.08 1.13
    Pivot Point 1.04 1.04 1.03 1.04 1.04
    Support 1 (S1) 1.01 1.01 0.99 1.02 0.97
    Support 2 (S2) 0.97 1.00 0.97 0.97
    Support 3 (S3) 0.94 0.97 0.96
    Support 4 (S4) 0.95